Trends in opioid prescribing and co-prescribing of sedative hypnotics for acute and chronic musculoskeletal pain: 2001-2010

Pharmacoepidemiology and Drug Safety

Volumn 24, Issue 8, 2015, Pages 885-892

  Larochelle, Marc R ^a,b   Zhang, Fang ^a   Ross Degnan, Dennis ^a   Wharam, J Frank ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Benzodiazepine; Musculoskeletal pain; Opioid; Pharmacoepidemiology; Sedative hypnotic

Indexed keywords

BENZODIAZEPINE; HYPNOTIC SEDATIVE AGENT; MUSCLE RELAXANT AGENT; OPIATE; NARCOTIC ANALGESIC AGENT;

ACUTE MUSCULOSKELETAL PAIN; ADULT; AGED; ARTICLE; CHRONIC MUSCULOSKELETAL PAIN; CHRONIC PAIN; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HEALTH CARE SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MUSCULOSKELETAL PAIN; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; TREATMENT OUTCOME; TREND STUDY; ACUTE PAIN; ADOLESCENT; CLINICAL PRACTICE; COMBINATION DRUG THERAPY; COMPARATIVE STUDY; DRUG USE; FACTUAL DATABASE; MULTIVARIATE ANALYSIS; PHARMACOEPIDEMIOLOGY; RISK FACTOR; STATISTICAL MODEL; TIME FACTOR; TRENDS; UNITED STATES; YOUNG ADULT;

ACUTE PAIN; ADOLESCENT; ADULT; AGED; ANALGESICS, OPIOID; CHRONIC PAIN; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; DRUG PRESCRIPTIONS; DRUG THERAPY, COMBINATION; DRUG UTILIZATION REVIEW; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUSCULOSKELETAL PAIN; PHARMACOEPIDEMIOLOGY; PRACTICE PATTERNS, PHYSICIANS'; RISK FACTORS; TIME FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84938964613     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3776     Document Type: Article

References (31)

1. Centers for Disease Control and Prevention (CDC). Vital signs: overdoses of prescription opioid pain relievers - United States, 1999-2008. MMWR Morb. Mortal. Wkly Rep. 2011; 60(43): 1487-1492.
2. Jones CM, Mack KA, Paulozzi LJ. Pharmaceutical overdose deaths, United States, 2010. JAMA 2013; 309(7): 657-659.
3. Caudill-Slosberg MA, Schwartz LM, Woloshin S. Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs. 2000. Pain 2004; 109(3): 514-519.
4. Boudreau D, Von Korff M, Rutter CM, et al. Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol. Drug Saf. 2009; 18(12): 1166-1175.
5. Catan T, Perez E. A pain-drug champion has second thoughts. Wall Street Journal. December 17, 2012 2012;U.S. News. Available from: http://www.wsj.com/articles/SB10001424127887324478304578173342657044604. Accessed July 10, 2013.
6. Alexander G, Kruszewski SP, Webster DW. Rethinking opioid prescribing to protect patient safety and public health. JAMA 2012; 308(18): 1865-1866.
7. Von Korff M, Kolodny A, Deyo RA, Chou R. Long-term opioid therapy reconsidered. Ann. Intern. Med. 2011; 155(5): 325-328.
8. Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J. Pain 2009; 10(2): 113-130.
9. Manchikanti L, Abdi S, Atluri S, et al. American society of interventional pain physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: part 2--guidance. Pain Physician 2012; 15(3 Suppl): S67-S116.
10. The Management of Opioid Therapy for Chronic Pain Working Group. VA/DOD clinical practice guideline for management of opioid therapy for chronic pain. http://www.healthquality.va.gov/guidelines/Pain/cot/COT_312_Full-er.pdf. Updated 2010. Accessed June 20, 2014.
11. Rolfs RT, Johnson E, Williams NJ, Sundwall DN. Utah Department of Health. Utah clinical guidelines on prescribing opioids for treatment of pain. J. Pain Palliat. Care Pharmacother. 2010; 24(3): 219-235.
12. Deyo RA, Smith DH, Johnson ES, et al. Opioids for back pain patients: primary care prescribing patterns and use of services. J. Am. Board Fam. Med. 2011; 24(6): 717-727.
13. Hermos JA, Young MM, Gagnon DR, Fiore LD. Characterizations of long-term oxycodone/acetaminophen prescriptions in veteran patients. Arch. Intern. Med. 2004; 164(21): 2361-2366.
14. National Center for Health Statistics. About the ambulatory health care surveys. www.cdc.gov/nchs/ahcd/about_ahcd.htm. Published July 14, 2009. Accessed July 19, 2013.
15. Pletcher MJ, Kertesz SG, Kohn MA, Gonzales R. Trends in opioid prescribing by race/ethnicity for patients seeking care in US emergency departments. JAMA 2008; 299(1): 70-78.
16. Dunn KM, Saunders KW, Rutter CM, et al. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann. Intern. Med. 2010; 152(2): 85-92.
17. National Cancer Institute. Joinpoint user's guide 4.1.0. surveillance.cancer.gov/joinpoint/Joinpoint_Help_4.1.0.pdf. Published April 22, 2014. Accessed July 9, 2014.
18. Akaike H. A new look at the statistical model identification. IEEE Transactions on Automatic Control 1974; 19(6): 716-723.
19. Akaike H. Likelihood and the Bayes procedure. In: Bayesian statistics, Bernardo J, DeGroot M, Lindley D, Smith A (eds.). University Press: Valencia, 1980; 143-166.
20. Sullivan MD, Edlund MJ, Fan MY, Devries A, Brennan Braden J, Martin BC. Trends in use of opioids for non-cancer pain conditions 2000-2005 in commercial and medicaid insurance plans: the TROUP study. Pain 2008; 138(2): 440-449.
21. Daubresse M, Chang HY, Yu Y, et al. Ambulatory diagnosis and treatment of nonmalignant pain in the United States, 2000-2010. Med. Care 2013; 51(10): 870-878.
22. Bohnert AS, Valenstein M, Bair MJ, et al. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA 2011; 305(13): 1315-1321.
23. Edlund MJ, Martin BC, Fan M, Devries A, Braden JB, Sullivan MD. Risks for opioid abuse and dependence among recipients of chronic opioid therapy: results from the TROUP study. Drug Alcohol Depend. 2010; 112(1-2): 90-98.
24. Edlund MJ, Steffick D, Hudson T, Harris KM, Sullivan M. Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain. Pain 2007; 129(3): 355-362.
25. Boscarino JA, Rukstalis M, Hoffman SN, et al. Risk factors for drug dependence among out-patients on opioid therapy in a large US health-care system. Addiction 2010; 105(10): 1776-1782.
26. Liebschutz JM, Saitz R, Weiss RD, et al. Clinical factors associated with prescription drug use disorder in urban primary care patients with chronic pain. J. Pain 2010; 11(11): 1047-1055.
27. Centers for Disease Control and Prevention (CDC). Overdose deaths involving prescription opioids among medicaid enrollees - Washington, 2004-2007. MMWR Morb. Mortal. Wkly Rep. 2009; 58(42): 1171-1175.
28. Weich S, Pearce HL, Croft P, et al. Effect of anxiolytic and hypnotic drug prescriptions on mortality hazards: retrospective cohort study. BMJ 2014: 348. doi:10.1136/bmj.g1996.
29. Garcia AM. State laws regulating prescribing of controlled substances: balancing the public health problems of chronic pain and prescription painkiller abuse and overdose. J. Law Med. Ethics 2013; 41(Suppl 1): 42-45.
30. Daubresse M, Gleason PP, Peng Y, Shah ND, Ritter ST, Alexander GC. Impact of a drug utilization review program on high-risk use of prescription controlled substances. Pharmacoepidemiol. Drug Saf. 2014; 23(4): 419-427.
31. Gonzalez AM, 3rd, Kolbasovsky A. Impact of a managed controlled-opioid prescription monitoring program on care coordination. Am. J. Manag. Care 2012; 18(9): 516-524.